Acquired ultrafiltration dysfunction in peritoneal dialysis patients

Journal of the American Society of Nephrology

Volumn 13, Issue 11, 2002, Pages 2787-2794

  Margetts, Peter J ^a   Churchill, David N ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DIALYSIS FLUID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; ICODEXTRIN; NITROPRUSSIDE SODIUM;

ARTICLE; HUMAN; MEMBRANE TRANSPORT; MORTALITY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL ULTRAFILTRATION DYSFUNCTION; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; ULTRAFILTRATION; UREMIA;

EID: 0036838302     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v13112787     Document Type: Article

References (80)

1. Gokal R: Taking peritoneal dialysis beyond the year 2000. Perit Dial Int 19(Suppl 3]: S35-S42, 1999
2. Davies SJ, Bryan J, Phillips L, Russell GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 498-506, 1996
3. Krediet RT, Lindholm B, Rippe B: Pathophysiology of peritoneal membrane failure. Perit Dial Int 20[Suppl 4]: S22-S42, 2000
4. Mactier RA, Khanna R, Twardowski ZJ, Nolph KD: Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption. Am J Kidney Dis 10: 461-466, 1987
5. Devuyst O, Nielsen S, Cosyns JP, Smith BL, Agre P, Squifflet JP, Pouthier D, Goffin E: Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 275: H234-H242, 1998
6. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320, 2002
7. Churchill DN: The ADEMEX study: Make haste slowly. J Am Soc Nephrol 13: 1415-1418, 2002
8. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38: 495-506, 1990
9. Smit W, Langedijk MJ, Schouten N, van den BN, Struijk DG, Krediet RT: A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function. Perit Dial Int 20: 734-741, 2000
10. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT: Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 17: 144-150, 1997
11. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S, Krediet R, Lindholm B, Oreopoulos D, Rippe B, Selgas R: Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 20[Suppl 4]: S5-21, 2000
12. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, Movilli E: CAPD viability: A long-term comparison with hemodialysis. Perit Dial Int 16: 276-287, 1996
13. Kawaguchi Y: National comparisons: Optimal peritoneal dialysis outcomes among Japanese patients. Perit Dial Int 19 Suppl 3: S9-16, 1999
14. Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study. Nephron 33: 133-138, 1983
15. De Vriese AS, Mortier S, Lameire NH: What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 21[Suppl 3]: S9-18, 2001
16. Heimburger O, Wang T, Lindholm B: Alterations in water and solute transport with time on peritoneal dialysis. Perit Dial Int 19[Suppl 2]: S83-S90, 1999
17. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Hoek FJ, Arisz L: A prospective study of peritoneal transport in CAPD patients. Kidney Int 45: 1739-1744, 1994
18. Lo WK, Brendolan A, Prowant BF, Moore HL, Khanna R, Twardowski ZJ, Nolph KD: Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 4: 1466-1474, 1994
19. Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40: 315-325, 1991
20. Rippe B, de Arteaga J, Venturoli D: Aquaporins are unlikely to be affected in marked ultrafiltration failure: Results from a computer simulation. Perit Dial Int 21 [Suppl 3]: S30-S34, 2001
21. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT, Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002
22. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19: 517-525, 1999
23. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13: 721-728, 2002
24. Monquil MC, Imholz AL, Struijk DG, Krediet RT: Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 15: 42-48, 1995
25. Goffin E, Combet S, Jamar F, Cosyns JP, Devuyst O: Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kid Disease 33: 383-388, 1999
26. Pollock CA, Ibels LS, Hallett MD, Cocksedge B, Caterson RJ, Mahony JF, Farrell PC: Loss of ultrafiltration in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 107-110, 1989
27. Flessner MF: Changes in the peritoneal interstitium and their effect on peritoneal transport. Perit Dial Int 19[Suppl 2]: S77-S82, 1999
28. Fussholler A, zur NS, Grabensee B, Plum J: Peritoneal fluid and solute transport: Influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 13: 1055-31060, 2002
29. Zweers MM, Splint LJ, Krediet RT, Struijk DG: Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol Dial Transplant 16: 651-654, 2001
30. Mortier S, De Vriese AS, Van d, V, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 13: 480-489, 2002
31. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051, 2001
32. Selgas R, Bajo MA, Castro MJ, del Peso G, Aguilera A, Fernandez-Perpen A, Cirugeda A, Sanchez-Tomero JA: Risk factors responsible for ultrafiltration failure in early stages of peritoneal dialysis. Perit Dial Int 20: 631-636, 2000
33. Tauer A, Knerr T, Niwa T, Schaub TP, Lage C, Passlick-Deetjen J, Pischetsrieder M: In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem Biophys Res Commun 280: 1408-1414, 2001
34. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A: Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12: 2434-2441, 2001
35. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele dS, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 463: 260-264, 1999
36. Ates K, Koc R, Nergizoglu G, Erturk S, Keven K, Sen A, Karatan O: The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int 20: 220-226, 2000
37. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kid Disease 35: 644-652, 2000
38. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O: Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 10: 2185-2196, 1999
39. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC, Gauldie J: Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 160: 2285-2294, 2002
40. Combet S, Ferrier ML, Van Landschoot M, Stoenoiu M, Moulin P, Miyata T, Lameire N, Devuyst O: Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 12: 2146-2157, 2001
41. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B: Does a high peritoneal transport rate reflect a state of chronic inflammation? Am J Kid Disease 19: 17-22, 1999
42. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16: 2240-2245, 2001
43. Margetts PJ, McMullin JP, Rabbat CG, Churchill DN: Peritoneal membrane transport and hypoalbuminemia: Cause or effect? Perit Dial Int 20: 14-18, 2000
44. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292, 1998
45. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 13: 1242-1249, 1998
46. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, Duman N, Karatan O, Ertug AE: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60: 767-776, 2001
47. Davies SJ, Phillips L, Russell GI: Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 13: 962-968, 1998
48. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, Hawkins KL, Morgan K, Nevarez M, Wood B: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 6: 198-206, 1995
49. Bos WJ, Struijk DG, van Olden RW, Arisz L, Krediet RT: Elevated 24-hour blood pressure in peritoneal dialysis patients with ultrafiltration failure. Adv Peritoneal Dial 14: 108-110, 1998
50. Jones CH, Smye SW, Newstead CG, Will EJ, Davison AM: Extracellular fluid volume determined by bioelectric impedance and serum albumin in CAPD patients. Nephrol Dial Transplant 13: 393-397, 1998
51. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G: Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 39: 872-875, 2002
52. Gokal R, Mistry CD, Peers EM: Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis. Perit Dial Int 15: 226-230, 1995
53. Mistry CD, Gokal R, Peers E: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 46: 496-503, 1994
54. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, Donker AJ: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 12: 550-553, 1997
55. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM: Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 15: 862-866, 2000
56. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K: Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2: 2, 2001
57. Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, Faict D, Topley N: Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a longterm improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 13 [Suppl 1]: S97-S103, 2002
58. Park MS, Kim JK, Holmes C, Weiss MF: Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation. Perit Dial Int 20[Suppl 5]: S33-S38, 2000
59. Coles GA, Gokal R, Ogg C, Jani F, O'Donoghue DT, Cancarini GC, Maiorca R, Tranaeus A, Faict D, De Vos C, Cancarinu GC: A randomized controlled trial of a bicarbonate- and a bicarbonate/lactatecontaining dialysis solution in CAPD. Perit Dial Int 17: 48-51, 1997
60. Tranaeus A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution-clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20: 516-523, 2000
61. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59: 348-357, 2001
62. Jones S, Holmes CJ, Krediet RT, Mackenzie R, Faict D, Tranaeus A, Williams JD, Coles GA, Topley N, Bicarbonate/Lactate Study Group: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59: 1529-1538, 2001
63. Plum J, Fussholler A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B: In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Nephrol Dial Transplant 12: 1652-1660, 1997
64. Smit W, de Waart DR, Struijk DG, Krediet RT: Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis. Peritoneal Dial Int 20: 557-565, 2000
65. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT: Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 46: 333-340, 1994
66. Breborowicz A, Polubinska A, Moberly J, Ogle K, Martis L, Oreopoulos D: Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis [computer file] 37: 594-600, 2001
67. Guo QY, Peng WX, Cheng HH, Ye RG, Lindholm B, Wang T: Hyaluronan preserves peritoneal membrane transport properties. Perit Dial Int 21: 136-142, 2001
68. Rosengren BI, Carlsson O, Rippe B: Hyaluronan and peritoneal ultrafiltration: A test of the 'filter-cake' hypothesis. Am J Kidney Dis 37: 1277-1285, 2001
69. Chan H, Abraham G, Oreopoulos DG: Oral lecithin improves ultrafiltration in patients on peritoneal dialysis [see comments]. Perit Dial Int 9: 203-205, 1989
70. Krack G, Viglino G, Cavalli PL, Gandolfo C, Magliano G, Cantaluppi A, Peluso F: Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients [see comments]. Perit Dial Int 12: 359-364, 1992
71. Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT: Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 53: 1014-1021, 1998
72. Ferrier ML, Combet S, Van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, Devuyst O: Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 60: 2343-2350, 2001
73. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, Akcicek F, Atabay G: Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 21: 219-224, 2001
74. Ripley EB, Gehr TW, Kish CW, Sica DA: Hormonal, blood pressure, and peritoneal transport response to short-term ACE inhibition. Perit Dial Int 14: 378-383, 1994
75. de Alvaro F, Castro MJ, Dapena F, Bajo MA, Fernandez-Reyes MJ, Romero JR, Jimenez C, Miranda B, Selgas R: Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure. Adv Perit Dial 9: 56-61, 1993
76. Bazzato G, Coli U, Landini S, Lucatello S, Fracasso A, Righetto F, Scanferla F, Morachiello P: Restoration of ultrafiltration capacity of peritoneal membrane in patients on CAPD. Int J Artificial Organs 7: 93-96, 1984
77. Churchill DN: Patient selection for automated peritoneal dialysis on the basis of peritoneal transport characteristics. Contrib Nephrol 129: 69-74, 1999
78. Ortega O, Gallar P, Carreno A, Gutierrez M, Rodriguez I, Oliet A, Vigil A, Gimenez E: Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: Influence on blood pressure control. Am J Nephrol 21: 189-193, 2001
79. Wang MC, Tseng CC, Tsai WC, Huang JJ: Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int 21: 36-42, 2001
80. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol 12: 2158-2162, 2001